TEST BANK FOR Advanced Practice Nursing
l# l# l# l# l#
l# in the Care of Older Adults, 3rd Edition
l# l# l# l# l# l# l# l#
by Laurie Kennedy-Malone, Verified Chapters 1 - 23,
l# l# l# l# l# l# l#
l# Comple
te
,Answers at the end of the Chapter
l# l# l# l# l# l# l#
Chapter 1: Changes with Aging l# l# l# l#
Multiple l#Choice
Identify l#the l#choice l#that l#best l#completes l#the l#statement l#or l#answers l#the l#question.
1. The major impact of the physiological changes that occur with aging is:
l# l# l# l# l# l# l# l# l# l# l#
A. Reduced l#physiological l#reserve
B. Reduced l#homeostatic l#mechanisms
C. Impaired l#immunological l#response
D. All l#of l#the l#above
2. The strongest evidence regarding normal physiological aging is available
l# l# l# l# l# l# l# l#
through:
l#
,A. Randomized l#controlled l#clinical l#trials
B. Cross-sectional l#studies
C. Longitudinal l#studies
D. Case l#control l#studies
l# l# l# 3. All of the following statements are true about laboratory
l# l# l# l# l# l# l# l# l#
values in older adultsexcept:
l# l# l#
A. Reference l#ranges l#are l#preferable
B. Abnormal l#findings l#are l#often l#due l#to l#physiological l#aging
C. Normal l#ranges l#may l#not l#be l#applicable l#for l#older l#adults
D. Reference l#values l#are l#not l#necessarily l#acceptable l#values
l# l# l# 4. l # Biochemical individuality is best described as:
l# l# l# l# l#
A. Each l#individual’s l#variation l#is l#often l#much l#greater l#than l#that l#of l#a l#larger l#group
B. The l#unique l#biochemical l#profile l#of l#a l#selected l#population
C. The l#truly l#“normal” l#individual—falling l#within l#average l#range
D. Each l#individual’s l#variation l#is l#often l#much l#smaller l#than l#that l#of l#a l#larger l#group
l# l# l# 5. l # Polypharmacy is best described as taking:
l# l# l# l# l#
A. More l#than l#nine l#medications l#per l#day
B. More l#than l#five l#medications l#per l#day
, C. Even l#a l#single l#medication l#if l#there l#is l#not l#a l#clear l#indication l#for l#its l#use
D. When l#a l#drug l#is l#given l#to l#treat l#the l#side l#effect l#of l#another l#drug
l# l# l# 6. l # Pharmacokinetic changes with aging is reflective of:
l# l# l# l# l# l#
A. What l#the l#drug l#does l#to l#the l#body
B. What l#the l#body l#does l#to l#the l#drug
C. The l#effect l#at l#the l#site l#of l#action l#and l#the l#time l#and l#intensity l#of l#the l#drug
D. The l#side l#effects l#commonly l#associated l#with l#the l#drug
l# l#7. l# l# All the following statements are false about drug absorption
l# l# l# l# l# l# l# l#
except:
l#
A. Antacids l#increase l#the l#bioavailability l#of l#digitalis
B. Gastric l#acidity l#decreases l#with l#age
C. Anticholinergics l#increase l#colonic l#motility
D. Underlying l#chronic l#disease l#has l#little l#impact l#on l#drug l#absorption
l# l#8. All of the following statements are true about drug distribution
l# l# l# l# l# l# l# l# l# l# l#
in the
l# l#
elderly except:l#
A. Drugs l#distributed l#in l#water l#have l#lower l#concentration
B. Drugs l#distributed l#in l#fat l#have l#less l#intense, l#more l#prolonged l#effect
C. Drugs l#highly l#protein l#bound l#have l#greater l#potential l#to l#cause l#an l#adverse l#drug l#reaction
l# l# l# l# l#
l# in the Care of Older Adults, 3rd Edition
l# l# l# l# l# l# l# l#
by Laurie Kennedy-Malone, Verified Chapters 1 - 23,
l# l# l# l# l# l# l#
l# Comple
te
,Answers at the end of the Chapter
l# l# l# l# l# l# l#
Chapter 1: Changes with Aging l# l# l# l#
Multiple l#Choice
Identify l#the l#choice l#that l#best l#completes l#the l#statement l#or l#answers l#the l#question.
1. The major impact of the physiological changes that occur with aging is:
l# l# l# l# l# l# l# l# l# l# l#
A. Reduced l#physiological l#reserve
B. Reduced l#homeostatic l#mechanisms
C. Impaired l#immunological l#response
D. All l#of l#the l#above
2. The strongest evidence regarding normal physiological aging is available
l# l# l# l# l# l# l# l#
through:
l#
,A. Randomized l#controlled l#clinical l#trials
B. Cross-sectional l#studies
C. Longitudinal l#studies
D. Case l#control l#studies
l# l# l# 3. All of the following statements are true about laboratory
l# l# l# l# l# l# l# l# l#
values in older adultsexcept:
l# l# l#
A. Reference l#ranges l#are l#preferable
B. Abnormal l#findings l#are l#often l#due l#to l#physiological l#aging
C. Normal l#ranges l#may l#not l#be l#applicable l#for l#older l#adults
D. Reference l#values l#are l#not l#necessarily l#acceptable l#values
l# l# l# 4. l # Biochemical individuality is best described as:
l# l# l# l# l#
A. Each l#individual’s l#variation l#is l#often l#much l#greater l#than l#that l#of l#a l#larger l#group
B. The l#unique l#biochemical l#profile l#of l#a l#selected l#population
C. The l#truly l#“normal” l#individual—falling l#within l#average l#range
D. Each l#individual’s l#variation l#is l#often l#much l#smaller l#than l#that l#of l#a l#larger l#group
l# l# l# 5. l # Polypharmacy is best described as taking:
l# l# l# l# l#
A. More l#than l#nine l#medications l#per l#day
B. More l#than l#five l#medications l#per l#day
, C. Even l#a l#single l#medication l#if l#there l#is l#not l#a l#clear l#indication l#for l#its l#use
D. When l#a l#drug l#is l#given l#to l#treat l#the l#side l#effect l#of l#another l#drug
l# l# l# 6. l # Pharmacokinetic changes with aging is reflective of:
l# l# l# l# l# l#
A. What l#the l#drug l#does l#to l#the l#body
B. What l#the l#body l#does l#to l#the l#drug
C. The l#effect l#at l#the l#site l#of l#action l#and l#the l#time l#and l#intensity l#of l#the l#drug
D. The l#side l#effects l#commonly l#associated l#with l#the l#drug
l# l#7. l# l# All the following statements are false about drug absorption
l# l# l# l# l# l# l# l#
except:
l#
A. Antacids l#increase l#the l#bioavailability l#of l#digitalis
B. Gastric l#acidity l#decreases l#with l#age
C. Anticholinergics l#increase l#colonic l#motility
D. Underlying l#chronic l#disease l#has l#little l#impact l#on l#drug l#absorption
l# l#8. All of the following statements are true about drug distribution
l# l# l# l# l# l# l# l# l# l# l#
in the
l# l#
elderly except:l#
A. Drugs l#distributed l#in l#water l#have l#lower l#concentration
B. Drugs l#distributed l#in l#fat l#have l#less l#intense, l#more l#prolonged l#effect
C. Drugs l#highly l#protein l#bound l#have l#greater l#potential l#to l#cause l#an l#adverse l#drug l#reaction
